Ultrasensitive Blood Biomarker Detection for Precision Health and Research

June 3 | 11:30 AM – 1:30 PM | Mount Sinai Hospital

1468 Madison Ave, New York, NY 10029
Annenberg Building, 20th Floor – Conference Room 20-01

Join us for an in-depth session on how Simoa® technology is advancing neurology and immunology research through ultra-sensitive biomarker detection, customizable assay solutions, and scalable automation. Whether you’re investigating neuroinflammation, neurodegeneration, or immune system responses, discover how Simoa can help you uncover deeper biological insights with unmatched accuracy and efficiency.

Hear from leading experts in the biomarker field — Dr. Lawrence Honig (Columbia University Irving Medical Center) and Dr. Fanny Elahi (Icahn School of Medicine at Mount Sinai) — as they share how Simoa has enhanced their research and enabled new discoveries. Engage directly with these KOLs through in-depth discussions and Q&A.

What We’ll Cover:

• How Simoa technology delivers unparalleled sensitivity and precision for detecting biomarkers in neurology and immunology
• Expanded capabilities in neuroinflammation and immune response research with our newest cytokine panel offerings
• Custom assay development options tailored to your specific biomarker targets and research needs across neurology and immunology
• A hands-on demo of the fully automated Simoa HD-X Analyzer® to see firsthand how it delivers high-throughput workflows with exceptional reproducibility
• Insights from KOLs on real-world applications of Simoa in neurology and immunology research

Discover how Simoa can elevate your research and streamline lab workflows. Reserve your spot today to take your research further.

Agenda:

Time	Topic	Speaker
11:30 AM	Arrival and lunch
12:00 PM	Welcome & Introduction	Alicia Francis, Account Manager, Quanterix
12:05 PM	Simoa Technology Overview	Adam Shepro, Principal Scientist, Strategic Collaborations, Quanterix
12:20 PM	Detection of Low Abundance Biomarkers in Alzheimer’s Disease and Related Dementias	Fanny Elahi, M.D., Ph.D., Associate Professor of Neurology, Neuroscience, Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai
12:35 PM	Relationship Between Various pTau Biomarkers within Alzheimer’s Community Cohorts	Lawrence Honig, M.D., Ph.D., Professor of Neurology, Columbia University Irving Medical Center, Taub Institute for Research on Alzheimer’s Disease and the Aging Brain
12:50 PM	Hands-on demonstration of the Simoa HD-X Analyzer® platform	Adam Shepro, Principal Scientist, Strategic Collaborations, Quanterix
1:05 PM	Networking
1:30 PM	Depart